The parallel importer

HvJ EG, 9 oktober 2008,  conclusie A-G Sharpston in zaak C-276/05, The Wellcome Foundation Ltd. tegen Paranova Pharmazeutika Handels GmbH. Verzoek om een prejudiciële beslissing ingediend door het Oberster Gerichtshof (Oostenrijk). (Nederlandse vertaling nog niet beschikbaar)

Eerst even voor jezelf lezen. Merkenrecht. Geneesmiddelen. Parallelimport. Ompakken. Bericht met uitleg aan de merkhouder.

“63. In the light of the above, I am of the view that the questions referred by the Oberster Gerichtshof, Austria, should be answered as follows:

(1) Where a parallel importer of pharmaceutical products repackages the products in new packaging on the ground that repackaging is necessary in order to market the product in the Member State of importation, the lawfulness of the new packaging is to be measured solely against whether it is such as to damage the reputation of the trade mark and its proprietor.

(2)  In such circumstances, the parallel importer, in order to fulfil his duty of notification under Article 7 of the Trade Marks Directive as interpreted by the Court of Justice, must give the proprietor of the trade mark information which objectively demonstrates that the repackaging was necessary. Such information may, but need not necessarily, include identification of the Member State of export.”

Lees de conclusie hier.